Trial Profile
A phase I/II study of REX-002 for critical limb ischaemia in diabetic patients
Status:
Recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 08 Feb 2022
Price :
$35
*
At a glance
- Drugs REX 002 (Primary)
- Indications Peripheral ischaemia
- Focus Adverse reactions; Therapeutic Use
- 10 Aug 2016 New trial record